Value-Based Pionee | Evolent Health leads the charge in value-based care, offering integrated solutions that improve outcomes while reducing costs in a shifting healthcare landscape |
Financial Resilience | Explore EVH's robust revenue growth, with Q2 2024 seeing a 37.9% YoY increase to $647.1M, despite challenges in profitability and elevated utilization rates |
Strategic Expansion | Delve into Evolent's strategic moves, including the Machinify acquisition and new revenue agreements worth $70M, positioning the company for future growth |
Market Outlook | Analyst price targets range from $31 to $51, reflecting varied perspectives on EVH's ability to navigate Medicaid redeterminations and achieve its $300M EBITDA goal |
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Metrics to compare | EVH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVHPeersSector | |
---|---|---|---|---|
P/E Ratio | −29.2x | −4.9x | −0.6x | |
PEG Ratio | 1.13 | −0.04 | 0.00 | |
Price/Book | 2.9x | 1.0x | 2.6x | |
Price / LTM Sales | 1.3x | 1.8x | 3.2x | |
Upside (Analyst Target) | 55.2% | 38.2% | 44.2% | |
Fair Value Upside | Unlock | 32.9% | 7.9% | Unlock |